Log In
Print this Print this

AMR-102, AMR102

  Manage Alerts
Collapse Summary General Information
Company Amarin Corp. plc
DescriptionFixed-dose combination of rosuvastatin and Vascepa icosapent ethyl, a purified form of ethyl ester of eicosapentaenoic acid (ethyl-EPA)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase I
Standard Indication Cardiovascular (unspecified)
Indication DetailsReduce triglyceride levels
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today